Meloxicam vs Placebo for Mobilization

NCT02003625 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkin's Lymphoma
Hodgkin's Lymphoma
Multiple Myeloma
Hematopoietic Stem Cells

Interventions

DRUG: GCSF
DRUG: meloxicam
DRUG: Placebo

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]